Amphastar Pharmaceuticals (AMPH) Earnings Date & Reports

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

AMPH is expected to report earnings to fall 2.91% to 71 cents per share on August 11

Amphastar Pharmaceuticals AMPH Stock Earnings Reports

Q2'25

Est.

$0.72

Q1'25

Beat

by $0.05

Q4'24

Missed

by $0.05

Q3'24

Missed

by $0.04

Q2'24

Beat

by $0.17

The last earnings report on May 07 showed earnings per share of 74 cents, beating the estimate of 68 cents. With 510.68K shares outstanding, the current market capitalization sits at 2.11B.

View a ticker or compare two or three

Compare

AMPH